hrp0082p3-d3-790 | Fat Metabolism & Obesity (2) | ESPE2014

Obesity Correlates in Adolescence

Papandreou Ioannis , Kotsalidou Eleni , Tselenti Aikaterini , Gerle Zoi

Background: Adolescence represents a period of one’s life when profound mental and physiological adjustment take place marking the transition to adult life. Obesity is a common health issue amongst Greek adolescents often following an obese childhood.Objective and hypotheses: We intended to assess the dietary, lifestyle, and metabolic profile of adolescents followed at the outpatient clinic of our hospital.Methods: 253 adolesc...

hrp0086p2-p516 | Fat Metabolism and Obesity P2 | ESPE2016

4G Polymorphism of Plasminogen Activator Inhibitor-1 (PAI-1), PAI-1 Plasma Levels, and Lipid Profiles in Overweight/Obese Children and Adolescents

Karabouta Zacharoula , Makedou Areti , Papandreou Dimitrios , Argiriou Anagnostis , Xanthopoulou Helen , Rousso Israel , Athanassiadou-Piperopoulou Fani

Background: Studies have shown that PAI-1 4G polymorphism is related to increased plasma PAI-1 levels, obesity, dyslipidaemia and cardiovascular disease (CVD) in adults. Few studies have explored that relationship in overweight/obese (Ow/Ob) children/adolescents.Objective and hypotheses: We investigated the relation between plasma PAI-1 levels, PAI-1 4g polymorphisms and lipid profiles in Ow/Ob children/ adolescents compared with healthy normal ...

hrp0084p3-879 | Fat | ESPE2015

Cardiometabolic Risk Factors in Overweight/Obese Children and Adolescents and Family History of Cardiovascular Disease

Karabouta Zacharoula , Papandreou Dimitrios , Makedou Areti , Rousso Israel , Athanassiadou-Piperopoulou Fani

Background: Global prevalence of childhood obesity has increased from 4.2 to 6.7% in recent decades. Dyslipidaemia predisposes to cardiovascular disease (CVD) in adults. Family history (FH) of CVD is used as a screening tool for dyslipidaemia in children/ adolescents, however with controversial sensitivity.Objective and hypotheses: Purpose of the study was to identify and examine the effects of possible cardiovascular (CV) risk factors in overweight/obes...

hrp0082p1-d2-118 | Fat Metabolism & Obesity (1) | ESPE2014

Plasminogen Activator Inhibitor-1(Pai-1) Levels, Pai-1 Gene Polymorphism, and Family History of Cardiovascular Disease in Relation to Metabolic Parameters in a Sample of Obese Children

Karabouta Zacharoula , Makedou Areti , Argiriou Anagnostis , Papandreou Dimitrios , Xanthopoulou Eleni , Bisbinas Vasiliki , Athanassiadou-Piperopoulou Fani , Rousso Israel

Background: Obesity is a metabolic disorder associated with increased PAI-1 levels in the circulation. This increase is related to insulin resistance and cardiovascular disease (CVD). In adults the relationship between plasma PAI-1 levels and the 4G/5G gene polymorphism in the PAI-1 gene has been demonstrated, but few data exist in children.Objective and hypotheses: To assess the relationship between PAI-1 plasma levels and the PAI-1 4G allele gene polym...

hrp0086p2-p790 | Pituitary and Neuroendocrinology P2 | ESPE2016

Precocious Puberty in a Girl With Prader Willi Syndrome

Papagianni Maria , Kosta Konstantina , Lialias Ioannis , Chatzakis Christos , Tsiroukidou Kiriaki , Tsanakas Ioannis

Background: Prader Willi Syndrome (PWS) is a rare genetic disorder with a wide range of symptoms manifestation. Main characteristics are hypotonia, growth retardation, feeding difficulties in neonatal period, increased appetite and obesity in childhood, delayed puberty or hypogonadism in adolescence. It is also associated with behavioral disturbances and impaired cognitive function. The genetic defect is located on the 15q11-13 chromosome.Objective and h...

hrp0084p3-615 | Adrenals | ESPE2015

Paraaortical Paragangliomas as Incidental Findings in a Female Adolescent

Mouzaki Konstantina , Kotanidou Eleni , Ioannidou Maria , Karaiskou Evangelia , Kyrgios Ioannis , Arsos Georgios , Tsitouridis Ioannis , Efstratiou Ioannis , Eboriadou-Petikopoulou Maria , Galli-Tsinopoulou Assimina

Background: Paragangliomas are exceptionally rare neuroendocrine tumours for children and adolescents, located in an extraadrenal position and usually producing catecholamine.Case presentation: A 13.5-year-old girl with a known history of multiple exostosis disease was presented for investigation of two large nodal oval para-aortic lesions, which were incidentally found during abdominal ultrasonography. Medical history of the girl included non-autoimmune...

hrp0089p2-p208 | GH & IGFs P2 | ESPE2018

A Novel, Synonymous, Heterozygous, Splicing Variant Affecting the Intracellular Domain of the Growth Hormone Receptor: Causality for Mild Growth Impairment and IGF-I Deficiency in an Affected Patient?

Efthymiadou Alexandra , Papanastasiou Anastasios , Zarkadis Ioannis , Hwa Vivian , Chrysis Dionysios

Introduction: Although the majority of Growth Hormone insensitivity syndrome (GHIS) cases are classical, the spectrum of clinical phenotypes has expanded to include ‘atypical’ GHIS subjects with milder phenotypes due to very rare heterozygous GHR mutations with dominant negative effects.Case description: A 13 year old pubertal boy was presented with short stature (−1.7SD) and delayed bone age (11 6/12). Final adult height was &#8...

hrp0086fc2.5 | Bone & Mineral Metabolism | ESPE2016

Determination of the Minimal Clinically Important Difference in the Six-Minute Walk Test for Patients with Hypophosphatasia

Tomazos Ioannis , Moseley Scott , Sawyer Eileen , Iloeje Uche

Background: Hypophosphatasia (HPP) is a rare, inherited, metabolic disease caused by loss-of-function mutation(s) in the gene encoding tissue nonspecific alkaline phosphatase (TNSALP). Poor skeletal mineralisation, muscle weakness, pain, and accompanying complications characteristic of HPP result in impaired physical function, decreasing ability to perform daily activities, and quality of life. Improvement in physical function is a treatment target, yet established physical ac...

hrp0082fc12.5 | Obesity | ESPE2014

Low Circulating Levels of DKK-1 Protein in Obese Children Indicate Suppression of Canonical Wnt Signaling

Kanaka-Gantenbein Christina , Terpos Evangelos , Chrousos George , Papassotiriou Ioannis

Background: Secretion of Wnt-proteins by adipose cells plays an important role in the control of adipogenesis. The Wnt-antagonist, dickkopf-1 (DKK-1), is secreted by human pre-adipocytes and influences adipocyte maturation and growth. DKK-1 mRNA increases 6 h after onset of human adipogenesis followed by an increase in DKK-1 protein. Of note, DKK-1 protein has been implicated also in bone remodeling pathways.Patients and Methods: In this study we measure...

hrp0082p1-d1-104 | Fat Metabolism & Obesity | ESPE2014

Coexistence of Elevated Chitinase 3-Like Protein 1 and von Willebrand Levels in Prepubertal Obese Children

Kyrgios Ioannis , Stylianou Charilaos , Kotanidou Eleni , Galli-Tsinopoulou Assimina

Introduction: Obesity as a chronic inflammatory disease is associated with impaired prothrombotic state leading to atherothrombosis. A variety of prothrombotic factors have been implicated in the pathophysiology of this phenomenon, especially the von Willebrand factor (vWF) produced in endothelium, megakaryocytes and subendothelial connective tissue. The aim of this study was to investigate any possible association between the new inflammatory marker chitinase 3-like protein 1...